Bhumsuk Keam - Publications, H-index & Citations

Bhumsuk Keam

Seoul National University Hospital

63H指数

696论文数

1.7W被引数

收录论文 179

发表时间

Immune Checkpoint Inhibitors in Resectable and Locoregionally Advanced HNSCC: Past Lessons, Present Evidence, and Future Directions 免疫检查点抑制剂在可切除和局部区域晚期头颈鳞状细胞癌中的应用：过去的经验、现有证据和未来方向

Oncologist

IF4.2

2026-09-17

OAAI

Kaewta Jeerapradit; Bhumsuk Keam; Nuttapong Ngamphaiboon

Addressing Existential Distress Through Compassion: Feasibility and Preliminary Effects of Compassion With You (COMwithU), a Compassion-Based Intervention for Patients With Cancer 通过慈悲缓解存在性痛苦：《与您同行之慈悲》（COMwithU），一种基于慈悲的癌症患者干预措施，其可行性及初步效果

Psycho-Oncology

IF3.5

2026-09-07

OAAI

Yeonkyu Choi; Jang Sub Kim; Hyejeong Ahn; Soowan Han; Min Cheol Seo; Jae Hyun Ryou; Da Eun Kim; Yoosuk An; Bhumsuk Keam; Tae-Yong Kim; Eun Seoung Yu; Hye Yoon Park

EZH1/2 inhibition selectively targets SMARCA4/2 co-deficient lung cancer cells by suppressing stemness and proliferation EZH1/2抑制通过抑制干性和增殖选择性靶向SMARCA4/2共缺陷肺癌细胞

Neoplasia

IF7.7

2026-08-01

PREAI

Lee, Jeongjae; Oh, Jaeik; Kim, Soyeon; Park, Taekeun; Youk, Jeonghwan; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Keam, Bhumsuk

In vitro evaluation of sacituzumab govitecan in non-small cell lung cancer with actionable genomic alterations 在具有可操作基因组改变的非小细胞肺癌中体外评估sacituzumab govitecan

Translational Oncology

IF4.1

2026-07-29

OAAI

Yerim Park; Soyeon Kim; Tae Min Kim; Miso Kim; Jeonghwan Youk; Dong-Wan Kim; Bhumsuk Keam

Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma 头颈部鳞状细胞癌复发后颈部淋巴结转移对免疫检查点抑制剂预后的影响

Cancer Immunology Immunotherapy

IF5.1

2026-07-24

OAAI

Dong Hyun Kim; Jiwon Koh; Yoon Kyung Jeon; Kyeong Cheon Jung; Jungirl Seok; Eun-Jae Chung; Seong-Keun Kwon; Soon-Hyun Ahn; Bhumsuk Keam

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study 局部晚期鼻咽癌根治性化放疗后巩固性帕博利珠单抗的随机II期临床试验：KCSG HN19-09，CONPELAN研究

Head and Neck-Journal for the Sciences and Specialties of the Head and Neck

IF2.2

2026-05-01

PREAI

Chun, Sang Hoon; Seo, Seyoung; Cho, Jang Ho; Park, Keon-Uk; Lee, Sang-Cheol; Choi, Yong Won; Yun, Tak; Shin, Seong Hoon; Kim, Sung-Bae; Lee, Seungeun; Ahn, Chang Ho; Keam, Bhumsuk

Documented advance care planning elements and end-of-life care patterns in malignant glioma vs. major solid tumors: a single-center retrospective study 记录的临终关怀计划要素和临终关怀模式在恶性胶质瘤与主要实体瘤中的比较：一项单中心回顾性研究

Journal of Neuro-Oncology

IF3.1

2025-12-29

PREAI

Ye Sul Jeung; Wan Taek Lee; Yejin Kim; Bhumsuk Keam; Tae Min Kim; Chul-Kee Park; Jin-Ah Sim; Shin Hye Yoo

Association between multidrug-resistant organism status and quality of end-of-life care in patients with advanced cancer referred to palliative care: a retrospective cohort study with nationwide data linkage 多药耐药菌状态与晚期癌症转诊姑息治疗患者临终关怀质量之间的关系：一项基于全国数据链接的回顾性队列研究

Clinical Microbiology and Infection

IF8.5

2025-12-02

OAAI

Jeong-Han Kim; Jiwon Yu; Wantaek Lee; Ye Sul Jeung; Shin Hye Yoo; Jin-Ah Sim; Bhumsuk Keam

Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study 皮下注射阿曼曲单抗在复发性/转移性头颈鳞状细胞癌中的应用：在免疫检查点抑制剂和化疗后疾病进展的患者中的初步结果，来自OrigAMI-4研究（1b/2期）

Oral Oncology

IF3.9

2025-11-22

OAAI

Kevin J. Harrington; Ari J. Rosenberg; Muh-Hwa Yang; Jessica L. Geiger; Marc Oliva; Myung-Ju Ahn; Sun Min Lim; William Ince; Aarti Bhatia; Siddharth Sheth; Bhumsuk Keam; Robert Metcalf; Joshua C. Curtin; Kiichiro Toyoizumi; Mark Wade; Emrullah Yilmaz; Priya Kim; Remy B. Verheijen; Sujay Shah; Mahadi Baig

Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and leptomeningeal metastases: The KCSG LU 21-01, LAZARUS study 拉泽替尼联合培美曲塞治疗表皮生长因子受体突变阳性非小细胞肺癌合并软脑膜转移的II期研究：KCSG LU 21-01、LAZARUS研究

Lung Cancer

IF4.4

2025-11-01

PREAI

Hyun-Ae Jung; Tae Min Kim; Hye Ryun Kim; Chang Gon Kim; Hee Kyung Ahn; Youngjoo Lee; Yu Jung Kim; Miso Kim; Jeonghwan Youk; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Dong-Wan Kim; Myung-Ju Ahn; Bhumsuk Keam

A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24)一项关于度鲁木单抗、多柔比星和异环磷酰胺用于复发性/或转移性肺肉瘤样癌的II期研究（KCSG LU-19-24）

Clinical Lung Cancer

IF3.3

2025-10-11

PREAI

Miso Kim; Jeonghwan Youk; Tae Min Kim; Gyeong-Won Lee; Dong-Wan Kim; Bhumsuk Keam

Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial 头颈部鳞状细胞癌中Alpelisib对不同PIK3CA突变位点的差异性疗效：来自KCSG HN 15-16 TRIUMPH试验的分析

CANCER RESEARCH AND TREATMENT

IF3.8

2025-10-01

PREAI

Kim, Kyoo Hyun; Hwang, Shinwon; Kim, Min Kyoung; Park, Keon-Uk; Yun, Tak; Lee, Keun-Wook; Kim, Joo Hang; Keam, Bhumsuk; Cho, Byoung Chul; Oh, So Yeon; Cho, Sang Hee; Kim, Sangwoo; Kim, Sung-Bae; Hong, Min Hee; Kim, Hye Ryun

Clinical Characteristics Associated with High [68Ga]Ga-PSMA-11 Uptake and Preliminary Therapeutic Outcomes in Patients with Metastatic Adenoid Cystic Carcinoma 转移性腺样囊性癌患者高 [68Ga]Ga-PSMA-11摄取的临床特征和初步治疗结果

Nuclear Medicine and Molecular Imaging

IF2.7

2025-10-01

OAAI

Sung, Hyunpil; Suh, Minseok; Gil, Joonhyung; Keam, Bhumsuk; Cheon, Gi Jeong; Kang, Keon Wook

Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)在伞形试验（KCSG HN 15-16 TRIUMPH试验）中识别头颈鳞状细胞癌的预测性生物标志物

ESMO Open

IF8.3

2025-09-17

PREAI

S. Hwang; M.H. Hong; S.H. Shin; T. Yun; K.-W. Lee; J.H. Kim; M.J. Ahn; B. Keam; H.W. Lee; M.K. Kim; H.J. Yun; Y. Kim; H.J. Kim; S.H. Cho; H.J. An; S.Y. Oh; S.-G. Park; Y.W. Koh; H.K. Ahn; J.H. Kwon; Y.-G. Lee; K.-U. Park; I.G. Hwang; S.-B. Kim; S. Kim; H.R. Kim

Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications

ESMO OPEN

IF8.3

2025-01-01

PREAI

Park, C.; Kim, R.; Bae, J. M.; Lee, T.; Song, S.; Kwak, Y.; Lee, K. B.; Youk, J.; Keam, B.; Kim, T. M.; Kim, D. -w.; Kim, J. -i.; Choi, J.; Kim, M.

Depression, performance status, and discontinued treatment mediate an association of curability belief with prognosis in advanced cancer patients

SCIENTIFIC REPORTS

IF3.9

2024-11-24

OAAI

Yun, Je-Yeon; Jung, Ju Youn; Keam, Bhumsuk; Lee, Na-Ri; Kang, Jung Hun; Kim, Yu Jung; Shim, Hyun-Jeong; Jung, Kyung Hae; Koh, Su-Jin; Ryu, Hyewon; Yoo, Shin Hyu; Kang, Eunkyo; Yun, Young Ho

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18 (vol 8, 101588, 2023)

ESMO OPEN

IF8.3

2024-11-01

OAAI

Kim, M.; Lee, J. L.; Shin, S. J.; Bae, W. K.; Lee, H. J.; Byun, J. H.; Choi, Y. J.; Youk, J.; Ock, C. Y.; Kim, S.; Song, H.; Park, K. H.; Keam, B.

Association between Tumor Size at the Time of Disease Progression and Survival Outcomes 疾病进展时肿瘤大小与生存结局之间的关联

CANCER RESEARCH AND TREATMENT

IF3.8

2024-10-22

OAAI

Maeng, Chi Hoon; Kim, Bum Jun; Ahn, Myung-Ju; Choi, In Sil; Zang, Dae Young; Kim, Bo-Hyung; Kwon, Minji; Heo, Dae Seog; Keam, Bhumsuk

Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment

CELLS

IF5.2

2024-09-16

OAAI

Kim, Dong Hyun; Ahn, Jong Seok; Kang, Mingu; Park, Gahee; Lim, Yoojoo; Hwang, Soohyun; Ock, Chan-Young; Koh, Jiwon; Chung, Eun-Jae; Kwon, Seong-Keun; Jeon, Yoon Kyung; Jung, Kyeong Cheon; Ahn, Soon-Hyun; Keam, Bhumsuk

Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-09-01

PREAI

Park, Siyeon; Park, Seongyeol; Kim, Tae Min; Kim, Soyeon; Koh, Jaemoon; Lim, Joonoh; Yi, Kijong; Yi, Boram; Ju, Young Seok; Kim, Miso; Keam, Bhumsuk; Kim, Jung Sun; Jeon, Yoon Kyung; Kim, Dong-Wan; Kim, Young Tae; Heo, Dae Seog

研究方向